Latest News

Risk for Preterm Birth Stops Maternal RSV Vaccine Trial


 

What’s Next for Other Vaccines

Maternal vaccines have been effective in preventing other diseases in infants, such as tetanus, influenza, and pertussis, but RSV is a very hard virus to make a vaccine for, Dr. Glatt shared.

The need is great to have more than one option for a maternal RSV vaccine, he added, to address any potential supply concerns.

“People have to realize how serious RSV can be in infants,” he said. “It can be a fatal disease. This can be a serious illness even in healthy children.”

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

New RSV vaccine will cut hospitalizations, study shows
MDedge ObGyn
News & Perspectives from Ob.Gyn. News
MDedge ObGyn
How clinicians can prepare for and defend against social media attacks
MDedge ObGyn
Some reasons to get off the fence about COVID booster
MDedge ObGyn
The 2024 Adult Vaccine Schedule Changes Are Here
MDedge ObGyn
Rubella Screening in Pregnancy No Longer Recommended in Italy
MDedge ObGyn
HPV Vaccine Shown to Be Highly Effective in Girls Years Later
MDedge ObGyn
RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified
MDedge ObGyn
HPV Positive Test: How to Address Patients’ Anxieties
MDedge ObGyn
Long-Term Follow-Up Emphasizes HPV Vaccination Importance
MDedge ObGyn